Grants And Publications
|
|
|
|
|
|
Biophysical properties of peptides representing endogenous processing of human prion protein
|
|
|
The University of Melbourne
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cu/Zn superoxide dismutase aggregation and neurodegeneration in sporadic motor neuron disease
|
|
|
Melbourne Research and Innovation Office
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Identification of a key aggregating protein in age-related macular degeneration
|
|
|
The University of Melbourne
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Targeted dopamine D1 receptor-positive cell ablation in adult mice: a generic model of neurodegeneration
|
|
|
Howard Florey Institute, University of Melbourne
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The effect of SOD1 on mitochondrial function in Familial Amyotrophic Lateral Sclerosis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Group Education Program for Family Caregivers of People Receiving Palliative Care
|
|
|
Centre for Palliative Care, St Vincent's Health & University Melbourne
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cell Apoptosis and inflammation in a mouse model of focal closed head injury
|
|
|
|
|
|
|
|
|
|
|
|
Maria Cristina Morganti-Kossmann
|
|
|
|
|
|
Analysing Proteolysis of Ataxin Proteins in Disease-Susceptible Regions of the Brain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Establishment of a Motor Neuron Disease Fluid and Brain Bank
|
|
|
Department of Anatomy & Cell Biology
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acceleration of oxidative stress in animal models of Parkinson's disease
|
|
|
Howard Florey Institute of Experimental Physiology and Medicine, The University of Melbourne
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mitochondrial Proteomic analysis of Familial Amyotrophic Lateral Sclerosis
|
|
|
Centre of Neuroscience, Univ of Melbourne
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A qualitative exploration of the needs of patients with severe COPD (Chronic obstructive pulmonary disease)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dysfunction of the seratonin system and dyskinesias in Parkinson's Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Do lymphocytes have reduced survival and increased secretion of a-synuclein in PD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Genetic factors determining susceptibility to PD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Determining the role of copper in transgenic Amyotrophic Lateral sclerosis models
|
|
|
Mental Health Research Institute
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Is Protein Disulphide Isomerase (PDI) a novel biomarker for MND
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Emotion recognition in MND, HD and MS: impact on communication, behaviour and carer burden
|
|
|
Calvary health Care Bethlehem
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The effects of altered metal homeostasis and oxidative stress on aggregation of endogenous TDP-43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patterns of hospitalisation for people with chronic obstructive pulmonary disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
understanding delusions in Alzheimer's disease
|
|
|
Mental Health Research Institute of Victoria
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Making new dopamine cells in the adult brain
|
|
|
|
|
|
|
|
|
Parkinsons Disease,Other,
|
|
|
|
|
|
|
|
|
New therapeutic approaches for MND based on ER stress inhibition
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Developing a new blood test for Parkinson’s Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Free radicals, stroke and recovery
|
|
|
Bernard O’Brien Institute of Microsurgery
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A study of how increased copper may be harmful in Amyotrophic Lateral Sclerosis
|
|
|
Mental Health Research Institute
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supporting Research Activities at CHCB
|
|
|
Calvary Health Care Bethlehem
|
|
|
|
|
|
Motor Neuron Disease,Other,
|
|
|
|
|
|
|
|
|
Targeting calcineurin to treat Alzheimer's disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Novel therapeutic agents for MND with optimal pharmokinetic properties
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Motoneuron death in ALS: differential insults together reflect total neuropathology
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise induced glial cell line-derived neurotrophic factor in Parkinson's disease
|
|
|
Howard Florey Institute of Experimental Physiology and Medicine, Univ of Melbourne
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Motor Neuron Disease research tissue bank
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
How Alzheimers antibodies recognise Abeta peptides
|
|
|
St Vincent’s Institute of Medical Research
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A central role for ER-Golgi trafficking in MND
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Are lymphocytes a model of neuronal dysfunction in PD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investigating nitric oxide as the cause of iron accumulation in PD
|
|
|
Mental Health Research Institute
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Toward better end stage cancer prognosticating: the Monash Prognostic Indicator
|
|
|
Monash Medical Centre, Southern Health
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Endosone-lysosome system dysregulation in MND
|
|
|
Florey Neuroscience Institutes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Single-cell gene expression profiling of adult midbrain dopamine neurogenesis
|
|
|
Florey Neuroscience Institutes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oxidatively modified variants of A-beta represent novel targets for therapy in Alzheimer's disease
|
|
|
The Mental Health Research Institute of Victoria
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Characterization of Alzheimer's disease Beta-secretase protein isoforms in human brain
|
|
|
Melbourne Research and Innovation Office
|
|
|
|
|
|
|
|
|
Ramsworth M. Damian Holsinger
|
|
|
|
|
|
Psychosocial adjustment of men with advanced prostate cancer
|
|
|
Centre for Palliative Care
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Do blood pressure modifying drugs given after stroke reduce the degree of brain damage
|
|
|
National Stroke Research Institute
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Do survival motor neuron complex deficits occur in MND
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Refinement and revalidation of the demoralisation scale
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Neural control behaviours associated with psychiatric symptoms in progressive neurological disorders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Endosone-lysosome system dysregulation in MND
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Can systems of ataxia be alleviated by various cereballomodulatory drugs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effectiveness of peer support intervention in MND
|
|
|
Calvary Health Care Bethlehem
|
|
|
|
|
|
Motor Neuron Disease,Palliative Care,
|
|
|
|
|
|
|
|
|
Self assembling nanofibrous hydrogel for repair of nigrostriatal pathway
|
|
|
|
|
|
|
|
|
Alzheimers Disease,Motor Neuron Disease,Multiple Sclerosis,Parkinsons Disease,Stroke,
|
|
|
|
|
|
|
|
|
|